Collier Katherine D, Vogtentanz Gudrun, Amin Neelam S, Estabrook Melodie, Estell David A, Fox Bryan, Power Scott D, Rao Roopali, Schmidt Brian F
Genencor International, A Division of Danisco, Inc., 925 Page Mill Road, Palo Alto, CA 94304, USA.
Protein Expr Purif. 2009 Dec;68(2):146-60. doi: 10.1016/j.pep.2009.08.006. Epub 2009 Aug 15.
Replacing the chymotrypsin inhibitory loop of soybean Bowman-Birk inhibitor (sBBI) with a VEGF binding peptide (BBI-AV) significantly reduces the overall purification yield when BBI-AV is produced as a fusion protein in a Bacillussubtilis expression system. The low purification yield is primarily due to a higher fraction of molecules with incorrect disulfide bond configurations after production and also after disulfide bond shuffling induced by 2-mercaptoethanol. To improve production yields, site-saturation libraries were generated at 39 out of the 66 amino acid residues of BBI-AV. Initial screens were designed to select for variants with higher trypsin inhibitory activities than the parent after treatment with a reducing agent. Secondary screens were developed to select for variants with the highest purification yields, and to also eliminate any false positives. From the screens, it was found that positively charged substitutions in the exposed hydrophobic patch region (sites 27, 29, 40, 50 & 52) are especially productive. In fact, one substitution, F50R, improves the purification yield to nearly the same level as wild-type sBBI. Productive amino acid substitutions were combined to select for the variant with the best overall yield after purification. Several variants were obtained with higher purification yields than even sBBI. The octuple variants, A13I-S25R-M27A-L29P-S31A-A40H-F50K-V52T and A13I-S25K-M27A-L29R-S31E-A40K-F50Q-V52Q, are particularly productive having greater than a five fold increase in final purification yield over the parent.
在枯草芽孢杆菌表达系统中,将大豆鲍曼-伯克抑制剂(sBBI)的胰凝乳蛋白酶抑制环替换为血管内皮生长因子(VEGF)结合肽(BBI-AV)并作为融合蛋白生产时,BBI-AV的整体纯化产率显著降低。纯化产率低主要是因为生产后以及经2-巯基乙醇诱导进行二硫键重排后,具有错误二硫键构型的分子比例更高。为提高产率,在BBI-AV的66个氨基酸残基中的39个处构建了位点饱和文库。初始筛选旨在选择在用还原剂处理后胰蛋白酶抑制活性高于亲本的变体。二次筛选旨在选择纯化产率最高的变体,并消除任何假阳性。通过筛选发现,暴露的疏水补丁区域(位点27、29、40、50和52)中的带正电荷取代特别有效。实际上,一个取代F50R将纯化产率提高到与野生型sBBI几乎相同的水平。将有效的氨基酸取代组合起来,以选择纯化后总体产率最佳的变体。获得了几个纯化产率甚至高于sBBI的变体。八重变体A13I-S25R-M27A-L29P-S31A-A40H-F50K-V52T和A13I-S25K-M27A-L29R-S31E-A40K-F50Q-V52Q特别有效,最终纯化产率比亲本提高了五倍以上。